Literature DB >> 18174155

Cooperative role of the membrane-proximal and -distal residues of the integrin beta3 cytoplasmic domain in regulation of talin-mediated alpha IIb beta3 activation.

Takaaki Hato1, Jun Yamanouchi, Tatsushiro Tamura, Yoshihiro Yakushijin, Ikuya Sakai, Masaki Yasukawa.   

Abstract

Integrin cytoplasmic tails regulate integrin activation that is required for high affinity binding with ligands. The interaction of the integrin beta subunit tail with a cytoplasmic protein, talin, largely contributes to integrin activation. Here we report the cooperative interaction of the beta3 membrane-proximal and -distal residues in regulation of talin-mediated alpha IIb beta3 activation. Because a chimeric integrin, alpha IIb beta3/beta1, in which the beta3 tail was replaced with the beta1 tail was constitutively active, we searched for the residues responsible for integrin activation among the residues that differed between the beta3 and beta1 tails. Single amino acid substitutions of Ile-719 and Glu-749 in the beta3 membrane-proximal and -distal regions, respectively, with the corresponding beta1 residues or alanine rendered alphaIIbbeta3 constitutively active. The I719M/E749S double mutant had the same ligand binding activity as alpha IIb beta3/beta1. These beta3 mutations also induced alphaVbeta3 activation. Conversely, substitution of Met-719 or Ser-749 in the beta1 tail with the corresponding beta3 tail residue (M719I or S749E) inhibited alpha IIb beta3/beta1 activation, and the M719I/S749E double mutant inhibited ligand binding to a level comparable with that of the wild-type alpha IIb beta3. Knock down of talin by short hairpin RNA inhibited the I719M- and E749S-induced alpha IIb beta3 activation. These results suggest that the beta3 membrane-proximal and -distal residues cooperatively regulate talin-mediated alpha IIb beta3 activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18174155     DOI: 10.1074/jbc.M707246200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Unique disulfide bonds in epidermal growth factor (EGF) domains of β3 affect structure and function of αIIbβ3 and αvβ3 integrins in different manner.

Authors:  Ronit Mor-Cohen; Nurit Rosenberg; Yulia Einav; Ehud Zelzion; Meytal Landau; Wissam Mansour; Yulia Averbukh; Uri Seligsohn
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

2.  Structure of an integrin alphaIIb beta3 transmembrane-cytoplasmic heterocomplex provides insight into integrin activation.

Authors:  Jun Yang; Yan-Qing Ma; Richard C Page; Saurav Misra; Edward F Plow; Jun Qin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-01       Impact factor: 11.205

3.  The structure of an integrin/talin complex reveals the basis of inside-out signal transduction.

Authors:  Nicholas J Anthis; Kate L Wegener; Feng Ye; Chungho Kim; Benjamin T Goult; Edward D Lowe; Ioannis Vakonakis; Neil Bate; David R Critchley; Mark H Ginsberg; Iain D Campbell
Journal:  EMBO J       Date:  2009-10-01       Impact factor: 11.598

4.  Structural diversity in integrin/talin interactions.

Authors:  Nicholas J Anthis; Kate L Wegener; David R Critchley; Iain D Campbell
Journal:  Structure       Date:  2010-12-08       Impact factor: 5.006

5.  L718P mutation in the membrane-proximal cytoplasmic tail of beta 3 promotes abnormal alpha IIb beta 3 clustering and lipid microdomain coalescence, and associates with a thrombasthenia-like phenotype.

Authors:  Asier Jayo; Isabel Conde; Pedro Lastres; Constantino Martínez; José Rivera; Vicente Vicente; Consuelo González-Manchón
Journal:  Haematologica       Date:  2010-01-15       Impact factor: 9.941

Review 6.  Mechanisms of talin-dependent integrin signaling and crosstalk.

Authors:  Mitali Das; Sujay Ithychanda; Jun Qin; Edward F Plow
Journal:  Biochim Biophys Acta       Date:  2013-07-24

Review 7.  The ins and outs of leukocyte integrin signaling.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.